Last reviewed · How we verify
Staphylococcus Peritonitis
Approved treatments
- Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Epocelin
- Ceftazidim · Tel-Aviv Sourasky Medical Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Staphylococcus Peritonitis patent landscape — cliff calendar, originator estates, attackable patents
- Staphylococcus Peritonitis treatment landscape brief
- Staphylococcus Peritonitis treatment updates RSS
Frequently asked questions about Staphylococcus Peritonitis
What drugs treat Staphylococcus Peritonitis?
Tracked treatments include Fortaz, Epocelin, Ceftazidim.
What is the treatment for Staphylococcus Peritonitis?
Standard treatment for Staphylococcus Peritonitis includes Fortaz, Epocelin, Ceftazidim. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Staphylococcus Peritonitis patent cliff · Staphylococcus Peritonitis CI report
- Treatment: Fortaz · Pai Holdings Pharm
- Treatment: Fortaz · Pai Holdings Pharm
- Treatment: Epocelin
- Treatment: Ceftazidim · Tel-Aviv Sourasky Medical Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing